The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-6.6% to $238.00
Predicted High$259.50at 1 month
Predicted Low$238.00at 6 months
Max Drawdown (predicted)-6.6%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 15, 2026 12:44 am
Bear
AME trends lower to
$238.00
(-6.6% from $254.79)
by Feb 2027.
ride-then-fade
ThesisAME is a quality compounder trading well above fair value, but risk-on tape, earnings momentum, and no near-term catalyst to force revaluation mean the stock likely drifts higher near-term before value gravity slowly reasserts over months.
Invalidated ifA break above $270 on strong volume or below $235 would invalidate the slow-fade thesis
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $254.79 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 15, 2026
—
$254.79at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 29, 2026
$243.09–$266.49typical range · internal point $257.20
—
±4.6%
6/10
Risk-on tape and post-beat momentum continue short-term
1 month
Sep 15, 2026
$237.83–$271.75typical range · internal point $259.50
—
±6.7%
5/10
Steady-compounder bid persists absent catalyst
2 months
Oct 15, 2026
$256.00
—
+0.5%
4/10
Pre-Q3 positioning, valuation friction emerges
3 months
Nov 15, 2026
$251.00
—
-1.5%
4/10
Q3 print likely beats but multiple pressured
4 months
Dec 15, 2026
$245.00
—
-3.8%
4/10
Year-end profit-taking on rich multiple
5 months
Jan 15, 2027
$242.00
—
-5.0%
3/10
January rotation away from expensive quality
6 months
Feb 15, 2027
$238.00
—
-6.6%
3/10
Value gravity slowly pulls toward anchored-PE fair value
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$235.96
(-7.4%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.